Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm
العنوان: | Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm |
---|---|
المؤلفون: | Ali Demircan, Mehmet Emin Sucu, Ozgur Artunay, Mevlüt Celal Öcal, Gokhan Demir, Dilek Yaşa, Cengiz Alagöz |
المصدر: | Lasers in Medical Science. 34:427-430 |
بيانات النشر: | Springer Science and Business Media LLC, 2018. |
سنة النشر: | 2018 |
مصطلحات موضوعية: | Male, medicine.medical_specialty, Bevacizumab, Retinal Artery, Fundus Oculi, Bilateral Disease, Angiogenesis Inhibitors, Dermatology, Light Coagulation, 030207 dermatology & venereal diseases, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, hemic and lymphatic diseases, Ophthalmology, medicine, Humans, Macula Lutea, Telangiectasis, Fluorescein Angiography, Intravitreal bevacizumab, Aged, Macular telangiectasia, Laser Coagulation, medicine.diagnostic_test, business.industry, Retinal, Arteries, 030206 dentistry, medicine.disease, Fluorescein angiography, Combined Modality Therapy, Aneurysm, chemistry, Intravitreal Injections, Surgery, sense organs, business, Tomography, Optical Coherence, medicine.drug |
الوصف: | Macular telangiectasia type 2 (Mac Tel 2) is a bilateral disease of unknown cause with characteristic changes of the retinal vasculature. To the best of our knowledge, we could not find any reported cases of Mac Tel 2 with retinal arterial macroaneurysm (RAM). Our aim is to report a case of Mac Tel 2 with RAM. |
تدمد: | 1435-604X 0268-8921 |
DOI: | 10.1007/s10103-018-2587-5 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e61ccbdf94e66277d46b8fe48598fc6 https://doi.org/10.1007/s10103-018-2587-5 |
Rights: | CLOSED |
رقم الانضمام: | edsair.doi.dedup.....8e61ccbdf94e66277d46b8fe48598fc6 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 1435604X 02688921 |
---|---|
DOI: | 10.1007/s10103-018-2587-5 |